Indian Pharma Stock with Promising Returns | Indian Stocks to Make You a Millionaire
  • Recover Lost Money Plan

    A number of traders have lost their money in the market due to wrong trading advice or wrong decisions and emotions. We keep on getting a number of requests for helping these traders recover their lost money. Thus, this was the genesis of Recover Lost Money Plan. We are proud to say that till date we have helped 1290 people recover their lost money. Recover Lost Money in Market

  • Our Most Successful Intraday Tip

    Jackpot tip, as the name suggests has the potential to make you a Millionaire as it is not the number of tips one trades; but it is the accuracy of a single tip which has the potential to make you a Millionaire. This tip is a value for money for all i.e whether one can see the trading terminal or not or is dealing through a broker on phone at BSE, NSE or in Future and Options segment.
    Click on Jackpot Sure Shot Tip to know more...

Subscribe to this blog

Subscribe to full feed RSS
What is Daily Market State???
Enter your Email

Preview | Powered by FeedBlitz

Indian Pharma Stock with Promising Returns

Posted By On 10:17 AM Under

1. A pharma stock worth keeping an eye is Sun Pharma as it has been showing a cionsistent growth even in times of recession. Moreover when its peers are struggling, it is growing by leaps and bounds. If we study its past ten years behaviour of the stock we will find that it has grown steadily by 28 per cent and has increased the revenues by 33 per cent on an average. One will be impressed with its profit margin which has grown impressively at an average 37 per cent (CAGR) over the period and average profit margins have stayed close to 24 per cent.

2. It has large presence in producing drugs related to lifestyle related diseases. Its main drug to treat diabetes is growing at 16 per cent CAGR and cardiovascular diseases drug is growing at 15 per cent CAGR and this uptrend is likely to continue considering the sedentary life style of the population.

3. Unlike its peers this stock company has been able to maintain its revenue guidance for the current year.

Most Read Content